Orexigen Therapeutics (OREX) and Takeda Pharmaceutical to Commercialize Contrave in North America
Orexigen Therapeutics is a biopharmaceutical company focused on the treatment of obesity. The company filed a New Drug Application (NDA)…
Orexigen Therapeutics is a biopharmaceutical company focused on the treatment of obesity. The company filed a New Drug Application (NDA)…
DEXO has been on a major slide recently, but appears to be prepared for at least a temporary bounce and…
Science-based nutraceutical company LifeVantage Corp. today announced the publication of a peer-reviewed study involving Protandim®, the company’s clinically proven therapy…
Although they have now branched out to a wide range of applications, National Automation Services built much of its reputation…
Need some help finding the “Next Big Thing”? Want stock tips on Quality Companies? The best thing is – It’s…
Resource Exchange of America Corp. is working to become a leader in the ferrous and nonferrous scrap metal industry. The…
Canadian Solar Inc. reported mixed financial results for the second quarter of 2010, with a sequential increase in net income…
Destination Maternity Corp. released the company’s sales and operations update for August 2010, and reported a decline in net sales…
Corporate Resource Services is a company on the move. Through its three wholly-owned subsidiaries, CRRS has established itself as a…
InoLife Technologies, Inc., a service-based healthcare products development, integration and marketing company, recently announced that it will market its proprietary…